ID: ALA3288937

Max Phase: Preclinical

Molecular Formula: C37H45FN4O6

Molecular Weight: 660.79

Molecule Type: Small molecule

Representations

Canonical SMILES:  COC(=O)C[C@H](NC(=O)OC(C)(C)C)C(=O)N(Cc1ccc(F)cc1)C1(C(=O)NCc2ccccc2)CCN(Cc2ccccc2)CC1

Standard InChI:  InChI=1S/C37H45FN4O6/c1-36(2,3)48-35(46)40-31(23-32(43)47-4)33(44)42(26-29-15-17-30(38)18-16-29)37(34(45)39-24-27-11-7-5-8-12-27)19-21-41(22-20-37)25-28-13-9-6-10-14-28/h5-18,31H,19-26H2,1-4H3,(H,39,45)(H,40,46)/t31-/m0/s1

Standard InChI Key:  VJVZWYZYRMKOCG-HKBQPEDESA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 660.79

Molecular Weight (Monoisotopic): 660.3323

AlogP: 4.96

#Rotatable Bonds: 12

Polar Surface Area: 117.28

Molecular Species: NEUTRAL

HBA: 7

HBD: 2

#RO5 Violations: 1

HBA (Lipinski): 10

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 13.19

CX Basic pKa: 8.30

CX LogP: 4.52

CX LogD: 3.57

Aromatic Rings: 3

Heavy Atoms: 48

QED Weighted: 0.26

Np Likeness Score: -0.92

References

1. de Castro S, Camarasa MJ, Balzarini J, Velázquez S..  (2014)  Discovery and SAR studies of a novel class of cytotoxic 1,4-disubstituted piperidines via Ugi reaction.,  83  [PMID:24956554] [10.1016/j.ejmech.2014.06.026]

2. de Castro S,Ginex T,Vanderlinden E,Laporte M,Stevaert A,Cumella J,Gago F,Camarasa MJ,Luque FJ,Naesens L,Velazquez S.  (2020)  N-benzyl 4,4-disubstituted piperidines as a potent class of influenza H1N1 virus inhibitors showing a novel mechanism of hemagglutinin fusion peptide interaction.,  194  [PMID:32220685] [10.1016/j.ejmech.2020.112223]

Source

Source(1):

• Scientific Literature